Corning Inc · GLW · FY2026 Q3 · Calendar Q4 2026
Corning’s optical growth accelerates, while solar remains a drag
The quarter supports a constructive operating thesis centered on optical communications, AI-related demand and carrier agreements, but the evidence is balanced by solar losses and execution risk around the pace of optical scale-up.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about GLW FY2026 Q3
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Q3 analysis described faster growth, stronger margins and $661 million of free cash flow, while highlighting that the SpringBoard plan had surpassed its $20 billion run-rate target. Management also outlined approximately $2 billion of 2026 capex, largely for optical capacity, and a display-glass price adjustment beginning in Q4 2026.
Guidance delta
Management maintained its outlook and indicated Q4 sales of $5.2-$5.3 billion and EPS of $0.96-$1.00.
Key takeaways
- Q3 sales rose 19% and EPS rose 36%, according to the supplied transcript analysis.
- Optical communications, enterprise AI demand and carrier agreements remained the primary growth drivers.
- The SpringBoard plan is ahead of its $20 billion run-rate target and points toward $40 billion by 2030.
- Solar demand is strong but the segment remains loss-making; management also outlined approximately $2 billion of 2026 capex.
Management priorities
- Expand optical communications capacity and high-density products for scale-up scenarios.
- Execute the SpringBoard plan toward a $40 billion sales target by 2030.
- Improve solar productivity and pursue customer agreements while maintaining the balance sheet, dividend and buyback program.
Follow GLW with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 27, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| JP Morgan | Neutral | Neutral | Maintain | Oct 21, 2026 |
| UBS | Buy | Buy | Maintain | Oct 5, 2026 |
| Truist Securities | Buy | Buy | Maintain | Oct 2, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Sep 15, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Jul 29, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jul 29, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 29, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 29, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jul 6, 2026 |
| Susquehanna | Positive | Positive | Maintain | Apr 29, 2026 |
| Argus Research | Buy | Buy | Maintain | Oct 29, 2025 |
| HSBC | Buy | Hold | Upgrade | Jan 30, 2025 |
| Deutsche Bank | Buy | Buy | Maintain | Oct 30, 2024 |
| Fox Advisors | Overweight | Equal Weight | Upgrade | Jun 17, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | Jul 26, 2023 |
| Goldman Sachs | Buy | Neutral | Upgrade | Jan 27, 2022 |
| Cross Research | Neutral | Buy | Downgrade | Sep 17, 2019 |
| Bank of America | Buy | Neutral | Upgrade | May 1, 2019 |
| Bernstein | Market Perform | Outperform | Downgrade | Feb 1, 2017 |
| Guggenheim | Buy | Buy | Maintain | Jan 4, 2017 |
| Wells Fargo | Perform | Market Perform | Maintain | Dec 21, 2016 |
| Standpoint Research | Hold | Buy | Downgrade | Jun 13, 2016 |
| Drexel Hamilton | Sell | Buy | Downgrade | Jun 10, 2016 |
| Sterne Agee CRT | Neutral | Neutral | Maintain | Sep 28, 2015 |
| Benchmark | Hold | Hold | Maintain | Jul 29, 2015 |
| RBC Capital | Outperform | Sector Perform | Upgrade | Jun 16, 2015 |
| CLSA | Sell | Underperform | Maintain | Apr 29, 2015 |
| Jefferies | Hold | Hold | Maintain | Feb 2, 2015 |
| Standpoint | Buy | Hold | Upgrade | Oct 15, 2014 |
| Stifel Nicolaus | Buy | Buy | Maintain | Oct 23, 2013 |
| Stifel | Buy | Buy | Maintain | Oct 23, 2013 |
| Sterne Agee | Neutral | Buy | Downgrade | Oct 23, 2013 |
| PiperJaffray | Neutral | Overweight | Downgrade | Oct 11, 2013 |
| Piper Sandler | Neutral | Overweight | Downgrade | Oct 11, 2013 |
| Gilford Securities | Buy | Buy | Maintain | Sep 23, 2013 |
| Cantor Fitzgerald | Hold | Hold | Maintain | Sep 19, 2013 |
| Topeka | Buy | Buy | Maintain | Nov 27, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $126.36. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Analyst unavailable | $201 | $164.16 | +59.1% | Oct 5, 2026 |
| Bernstein | Daniel Zhu | $140 | $158.75 | +10.8% | Sep 30, 2026 |
| Mizuho Securities | John Roberts | $180 | $143.5 | +42.4% | Sep 15, 2026 |
| Truist Financial | Analyst unavailable | $175 | $138.25 | +38.5% | Aug 2, 2026 |
| Morgan Stanley | Analyst unavailable | $165 | $125.88 | +30.6% | Jul 29, 2026 |
| Mizuho Securities | Analyst unavailable | $210 | $125.88 | +66.2% | Jul 29, 2026 |
| UBS | Joshua Spector | $196 | $125.88 | +55.1% | Jul 29, 2026 |
| Oppenheimer | Analyst unavailable | $200 | $125.88 | +58.3% | Jul 29, 2026 |
| Barclays | Tim Long | $129 | $125.88 | +2.1% | Jul 29, 2026 |
| Oppenheimer | Martin Yang | $230 | $194.77 | +82.0% | Jul 7, 2026 |
| UBS | Analyst unavailable | $243 | $196.7 | +92.3% | Jul 6, 2026 |
| Mizuho Securities | John Roberts | $270 | $255.54 | +113.7% | Jul 1, 2026 |
| Truist Financial | Matthew Niknam | $205 | $195 | +62.2% | Jun 22, 2026 |
| UBS | Joshua Spector | $228 | $197.93 | +80.4% | Jun 5, 2026 |
| Mizuho Securities | Analyst unavailable | $220 | $207.3 | +74.1% | May 12, 2026 |
| Morgan Stanley | Meta Marshall | $180 | $192.7 | +42.4% | May 8, 2026 |
| Barclays | Tim Long | $180 | $182.42 | +42.4% | May 8, 2026 |
| UBS | Analyst unavailable | $223 | $181.57 | +76.5% | May 7, 2026 |
| Truist Financial | Analyst unavailable | $149 | $149.3 | +17.9% | Apr 29, 2026 |
| Susquehanna | Analyst unavailable | $180 | $153.05 | +42.4% | Apr 29, 2026 |
| Barclays | Tim Long | $149 | $153.05 | +17.9% | Apr 29, 2026 |
| Morgan Stanley | Meta Marshall | $140 | $164.37 | +10.8% | Apr 20, 2026 |
| Mizuho Securities | Analyst unavailable | $160 | $165.1 | +26.6% | Apr 8, 2026 |
| Morgan Stanley | Analyst unavailable | $127 | $139.51 | +0.5% | Feb 23, 2026 |
| Mizuho Securities | Analyst unavailable | $145 | $139.51 | +14.7% | Feb 23, 2026 |
| HSBC | Stephen Bersey | $135 | $131.5 | +6.8% | Feb 13, 2026 |
| UBS | Joshua Spector | $125 | $105.58 | -1.1% | Jan 30, 2026 |
| Morgan Stanley | Analyst unavailable | $103 | $100.86 | -18.5% | Jan 29, 2026 |
| Oppenheimer | Analyst unavailable | $120 | $102.76 | -5.0% | Jan 29, 2026 |
| Susquehanna | Analyst unavailable | $125 | $104.29 | -1.1% | Jan 29, 2026 |
| Mizuho Securities | Analyst unavailable | $120 | $104.29 | -5.0% | Jan 29, 2026 |
| Barclays | Analyst unavailable | $100 | $104.29 | -20.9% | Jan 29, 2026 |
| Wolfe Research | George Notter | $130 | $110.98 | +2.9% | Jan 27, 2026 |
| Morgan Stanley | Meta Marshall | $98 | $86.29 | -22.4% | Dec 17, 2025 |
| UBS | Analyst unavailable | $109 | $78.03 | -13.7% | Nov 21, 2025 |
| Argus Research | Analyst unavailable | $110 | $91.56 | -13.0% | Oct 29, 2025 |
| UBS | Analyst unavailable | $100 | $87.5 | -20.9% | Oct 29, 2025 |
| Morgan Stanley | Analyst unavailable | $82 | $87.5 | -35.1% | Oct 29, 2025 |
| Mizuho Securities | Analyst unavailable | $97 | $86.43 | -23.2% | Oct 29, 2025 |
| Oppenheimer | Analyst unavailable | $100 | $87.5 | -20.9% | Oct 29, 2025 |
| Susquehanna | Analyst unavailable | $100 | $90.01 | -20.9% | Oct 29, 2025 |
| Barclays | Analyst unavailable | $83 | $86.43 | -34.3% | Oct 29, 2025 |
| Morgan Stanley | Analyst unavailable | $75 | $87.19 | -40.6% | Oct 10, 2025 |
| Mizuho Securities | Analyst unavailable | $90 | $82.52 | -28.8% | Oct 3, 2025 |
| UBS | Joshua Spector | $91 | $79.16 | -28.0% | Sep 23, 2025 |
| UBS | Analyst unavailable | $84 | $68.47 | -33.5% | Sep 2, 2025 |
| Mizuho Securities | John Roberts | $74 | $65.77 | -41.4% | Aug 8, 2025 |
| Morgan Stanley | Analyst unavailable | $56 | $62.61 | -55.7% | Jul 30, 2025 |
| Oppenheimer | Analyst unavailable | $72 | $62.61 | -43.0% | Jul 30, 2025 |
| Susquehanna | Analyst unavailable | $75 | $62.61 | -40.6% | Jul 30, 2025 |
| Mizuho Securities | John Roberts | $59 | $53.04 | -53.3% | Jul 15, 2025 |
| Mizuho Securities | John Roberts | $52 | $42 | -58.8% | Apr 15, 2025 |
| HSBC | Stephen Bersey | $60 | $49.8 | -52.5% | Jan 30, 2025 |
| Oppenheimer | Martin Yang | $58 | $48.84 | -54.1% | Oct 30, 2024 |
| Deutsche Bank | Matt Niknam | $54 | $49.03 | -57.3% | Oct 30, 2024 |
| Barclays | Tim Long | $53 | $49.03 | -58.1% | Oct 29, 2024 |
| Bank of America Securities | Wamsi Mohan | $56 | $49.03 | -55.7% | Oct 29, 2024 |
| Deutsche Bank | Matt Niknam | $49 | $45.66 | -61.2% | Oct 9, 2024 |
| Mizuho Securities | John Roberts | $51 | $44.65 | -59.6% | Sep 24, 2024 |
| Bank of America Securities | Wamsi Mohan | $51 | $44.3 | -59.6% | Sep 20, 2024 |
| Susquehanna | Mehdi Hosseini | $55 | $44.33 | -56.5% | Sep 20, 2024 |
| Oppenheimer | Martin Yang | $51 | $44.43 | -59.6% | Sep 20, 2024 |
| Citigroup | Asiya Merchant | $50 | $41.37 | -60.4% | Sep 6, 2024 |
| Mizuho Securities | John Roberts | $47 | $40.73 | -62.8% | Aug 21, 2024 |
| Bank of America Securities | Wamsi Mohan | $46 | $39.74 | -63.6% | Jul 31, 2024 |
| Deutsche Bank | Matt Niknam | $46 | $39.74 | -63.6% | Jul 31, 2024 |
| Morgan Stanley | Meta Marshall | $39 | $42.9 | -69.1% | Jul 26, 2024 |
| Argus Research | Jim Kelleher | $50 | $43.05 | -60.4% | Jul 9, 2024 |
| Mizuho Securities | John Roberts | $42 | $38.75 | -66.8% | Jun 18, 2024 |
| US Capital Advisors | Steve Fox | $45 | $37.25 | -64.4% | Jun 17, 2024 |
| Morgan Stanley | Meta Marshall | $38 | $38.02 | -69.9% | Jun 13, 2024 |
| UBS | Joshua Spector | $38 | $35.55 | -69.9% | May 30, 2024 |
| Mizuho Securities | John Roberts | $36 | $33.44 | -71.5% | May 7, 2024 |
| Susquehanna | Analyst unavailable | $40 | $35.68 | -68.3% | Feb 2, 2023 |
| Susquehanna | Mehdi Hosseini | $50 | $42.12 | -60.4% | Jan 30, 2022 |
| Barclays | Tim Long | $52 | $40.56 | -58.8% | Jan 27, 2022 |
| Oppenheimer | Martin Yang | $48 | $34.93 | -62.0% | Oct 27, 2021 |
Track every rating change on GLW the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationCorning Incorporated operates in optical communications, display, specialty materials, automotive, and life sciences businesses in the United States, Canada, Mexico, Japan, Taiwan, China, South Korea, Germany, and internationally. The company provides optical fibers and cables; and hardware and equipment products, such as cable assemblies, fiber optic hardware and connectors, optical components and couplers, closures, network interface devices, and other accessories for the telecommunications industry, businesses, governments, and individuals. It also offers glass substrates for flat panel displays, including liquid crystal displays and organic light-emitting diodes that are used in televisions, notebook computers, desktop monitors, tablets, and handheld devices.…
Historical context
All GLW earningsTechnology peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| CDNS Cadence Design Systems, Inc. | FY2026 Q3 · Calendar Q4 2026 | +2.9% | +1.8% | Cadence raises 2026 outlook as AI tools and verification demand accelerate |
| INFY Infosys Limited | FY2027 Q2 · Calendar Q4 2026 | -4.8% | -6.6% | Infosys trims growth outlook as AI revenue and deal wins accelerate |
| SSNC SS&C Technologies Holdings, Inc. | FY2026 Q3 · Calendar Q4 2026 | +0.6% | +2.8% | SS&C raises 2026 outlook as AI and tokenization support growth |
| ROP Roper Technologies, Inc. | FY2026 Q3 · Calendar Q4 2026 | +1.7% | +9.7% | Roper raises DEPS outlook as AI adoption expands across portfolio |
| VRSN VeriSign, Inc. | FY2026 Q3 · Calendar Q4 2026 | -2.0% | -0.9% | VeriSign reports record registrations as renewal mix becomes a key watchpoint |
| TTMI TTM Technologies, Inc. | FY2026 Q3 · Calendar Q4 2026 | +16.8% | -27.7% | TTM Technologies Q3: Record Growth, Higher Investment, More Deal Risk |
Latest beats and misses
Who reports nextBeat on EPS
- VZFY2026 Q3 · October 26, 2026+3.1% EPS-3.5% move
- CXFY2026 Q3 · October 26, 2026+12.0% EPS-0.1% move
- CDNSFY2026 Q3 · October 26, 2026+2.9% EPS+1.8% move
- BAHFY2027 Q2 · October 23, 2026+18.9% EPS-0.3% move
- FCNCAFY2026 Q3 · October 23, 2026+19.9% EPS+8.2% move
- FCNCNFY2026 Q3 · October 23, 2026+19.9% EPS+0.2% move
Missed on EPS
- PFGFY2026 Q3 · October 26, 2026-8.6% EPS+0.3% move
- WELLFY2026 Q3 · October 26, 2026-15.8% EPS-5.3% move
- KOFFY2026 Q3 · October 26, 2026-9.0% EPS-1.9% move
- INFYFY2027 Q2 · October 23, 2026-4.8% EPS-6.6% move
- BBDFY2026 Q3 · October 22, 2026-7.7% EPS+3.0% move
- SNAFY2026 Q3 · October 22, 2026-5.9% EPS-3.4% move
Get the GLW recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-10-27T16:13:50.575132+00:00
- FN2 earnings calendar · 2026-10-27T01:23:15.065758+00:00
- Polygon adjusted daily market bars · 2026-10-27T16:20:45.265463+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-27T16:20:45.263217+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-27. For educational purposes only; not investment advice.